The Lymphoma Academic Research Organisation

OrganisationROR

Trials

  • NCT07738887

    Phase 2, Not yet recruiting, 44 people, 31 Jul 2026

  • NCT06558604

    Phase 2, Recruiting, 100 people, 16 Aug 2024

  • NCT06284122

    Phase 3, Active, not recruiting, 790 people, 28 Feb 2024

  • NCT04802590

    Phase 2, Active, not recruiting, 210 people, 17 Mar 2021

  • NCT03458260

    Phase 2, Completed, 74 people, 8 Mar 2018

  • NCT03276468

    Phase 2, Completed, 136 people, 8 Sept 2017

  • NCT03225924

    Phase 1/2, Terminated, 25 people, 21 Jul 2017

  • NCT02896582

    Phase 2, Completed, 86 people, 12 Sept 2016

  • NCT02889523

    Phase 1/2, Active, not recruiting, 214 people, 5 Sept 2016

  • NCT02741388

    Phase 1, Completed, 39 people, 18 Apr 2016

  • NCT02686346

    Phase 1/2, Completed, 53 people, 19 Feb 2016

  • NCT02542514

    Phase 2, Completed, 52 people, 7 Sept 2015

  • NCT02414568

    Phase 2, Completed, 90 people, 10 Apr 2015

  • NCT02298283

    Phase 2, Completed, 40 people, 21 Nov 2014

  • NCT02292979

    Phase 2, Completed, 170 people, 18 Nov 2014

  • NCT02055924

    Phase 1, Terminated, 85 people, 5 Feb 2014

  • NCT01877005

    Phase 2, Completed, 33 people, 13 Jun 2013

  • NCT01771107

    Collaborator, Phase 1/2, Completed, 41 people, 18 Jan 2013

  • NCT01659099

    Phase 3, Terminated, 671 people, 7 Aug 2012

  • NCT01567475

    Phase 1, Completed, 21 people, 30 Mar 2012